Literature DB >> 29500795

The impact of log odds of positive lymph nodes (LODDS) in colon and rectal cancer patient stratification: a single-center analysis of 323 patients.

Andrea Scarinci1, Tatiana Di Cesare2, Daniele Cavaniglia2, Tiziano Neri2, Michelle Colletti3, Giulia Cosenza2, Andrea Liverani2.   

Abstract

Log odds of positive nodes (LODDS), defined as the log of the ratio between the number of positive nodes and the number of negative nodes, has been recently introduced as a tool in predicting prognosis. This study aims to establish the effective and prognostic value of LODDS in predicting the survival outcome of CRC patients undergoing surgical resection. The study population is represented by 323 consecutive patients with primary colon or rectal adenocarcinoma thatunderwent curative resection. LODDS values were calculated by empirical logistic formula, log(pnod + 0.5)/(tnod - pnod + 0.5). It was defined as the log of the ratio between the number of positive nodes and the number of negative nodes. The patients were divided into three groups: LODDS0 (≤ - 1.36), LODDS1 (> - 1.36 ≤ - 0.53) and LODDS2 (> - 0.53). Kaplan-Meier curve analyses showed 3-year OS rates of the patients staged by LODDS classification. These values were 88.3, 74.8 and 61.8% for LODDS0, LODDS1 and LODDS2, respectively (P ≤ 0.001). In a multivariate analysis, LODDS is an independent prognostic factor of 3-year OS. This is in contrast to pN stage and lymph node ratio, which shows no statistical significance. ROC analyses showed that LODDS predicted OS better than lymph node ratio. LODDS classification has a better prognostic effect than pN stage and lymph node ratio. LODDS offers a finer stratification and accurately predicts survival of CRC patients.

Entities:  

Keywords:  Adenocarcinoma; Colon cancer; LODDS; Lymph nodes; Rectum cancer

Mesh:

Year:  2018        PMID: 29500795     DOI: 10.1007/s13304-018-0519-3

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  20 in total

1.  Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection.

Authors:  Zhe Sun; Yan Xu; De Ming Li; Zhen Ning Wang; Guo Lian Zhu; Bao Jun Huang; Kai Li; Hui Mian Xu
Journal:  Cancer       Date:  2010-06-01       Impact factor: 6.860

2.  Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma.

Authors:  T Okusa; Y Nakane; T Boku; H Takada; M Yamamura; K Hioki; M Yamamoto
Journal:  Surg Gynecol Obstet       Date:  1990-06

3.  Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma?

Authors:  Paolo Aurello; Niccolò Petrucciani; Giuseppe R Nigri; Marco La Torre; Paolo Magistri; Simone Tierno; Francesco D'Angelo; Giovanni Ramacciato
Journal:  J Gastrointest Surg       Date:  2014-05-20       Impact factor: 3.452

4.  The prognostic impact of the log odds of positive lymph nodes in colon cancer.

Authors:  N C Arslan; S Sokmen; A E Canda; C Terzi; S Sarioglu
Journal:  Colorectal Dis       Date:  2014-11       Impact factor: 3.788

5.  Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.

Authors:  Leopoldo Sarli; Giovanni Bader; Domenico Iusco; Carlo Salvemini; Davide Di Mauro; Antonio Mazzeo; Gabriele Regina; Luigi Roncoroni
Journal:  Eur J Cancer       Date:  2005-01       Impact factor: 9.162

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

7.  Individual surgeon, pathologist, and other factors affecting lymph node harvest in stage II colon carcinoma. is a minimum of 12 examined lymph nodes sufficient?

Authors:  Luca Stocchi; Victor W Fazio; Ian Lavery; Jeff Hammel
Journal:  Ann Surg Oncol       Date:  2010-09-14       Impact factor: 5.344

Review 8.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

9.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Authors:  Robert Rosenberg; Jan Friederichs; Tibor Schuster; Ralf Gertler; Matthias Maak; Karen Becker; Anne Grebner; Kurt Ulm; Heinz Höfler; Hjalmar Nekarda; Jörg-Rüdiger Siewert
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

10.  The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients.

Authors:  Yen-Jung Lu; Pei-Ching Lin; Chun-Chi Lin; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Yuan-Tzu Lan; Tzu-Chen Lin; Wen-Yi Liang; Wei-Shone Chen; Jen-Kou Lin; Shih-Ching Chang
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

View more
  11 in total

1.  Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.

Authors:  Wonguen Jung; Kyubo Kim; Jiyoung Kim; Su Jung Shim
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection.

Authors:  Yanfei Lin
Journal:  BMC Surg       Date:  2022-07-04       Impact factor: 2.030

3.  Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapy.

Authors:  Tianlei Xu; Lin Zhang; Liang Yu; Yuelu Zhu; Hui Fang; Bo Chen; Haizeng Zhang
Journal:  Ann Transl Med       Date:  2021-04

4.  Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer.

Authors:  Jun-Peng Pei; Chun-Dong Zhang; Yu-Chen Fan; Dong-Qiu Dai
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

5.  A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme.

Authors:  Jun Zhu; Jun Hao; Qian Ma; Tingyu Shi; Shuai Wang; Jingchuan Yan; Rujie Chen; Dong Xu; Yu Jiang; Jian Zhang; Jipeng Li
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244

6.  The Prognostic Value of Log Odds of Positive Lymph Nodes in Early-Stage Esophageal Cancer Patients: A Study Based on the SEER Database and a Chinese Cohort.

Authors:  Kexing Xi; Wenyou Chen; Hui Yu
Journal:  J Oncol       Date:  2021-03-05       Impact factor: 4.375

7.  The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy.

Authors:  Zhuangbin Lin; Xiaobo Li; Jianyuan Song; Rong Zheng; Cheng Chen; Anchuan Li; Benhua Xu
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

8.  Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study.

Authors:  Hanlong Zhu; Si Zhao; Tianming Zhao; Kang Jiang; Lin Miao; Mingzuo Jiang; Fangyu Wang
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

9.  Comparison of Different Lymph Node Staging Schemes for Predicting Survival Outcomes in Node-Positive Endometrioid Endometrial Cancer Patients.

Authors:  Xi-Lin Yang; Nan Huang; Ming-Ming Wang; Hua Lai; Da-Jun Wu
Journal:  Front Med (Lausanne)       Date:  2021-07-09

10.  Significance of plasma MACC1 levels on the prognostic stratification in patients with colorectal cancer.

Authors:  Aifen Lin; Rui-Li Zhang; Xia Zhang; Xiao-Fang He; Jian-Gang Zhang; Wei-Hua Yan
Journal:  J Cell Mol Med       Date:  2018-10-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.